The University of Central Lancashire is proud to present its portfolio of Intellectual Property which covers a wide range of categories, including: Biomedical Sciences, Electrical and Electronic Engineering, Mechanical Engineering, Forensic Sciences, Nuclear Sciences, Materials and Nano-Materials Technologies, Tribology Technologies, Pharmacy and 3D Printing Technologies.
You can review the portfolio here or for more detail about a specific UCLan technology and answers to general questions about working with us or licensing our IP, please contact the innovation team at: firstname.lastname@example.org
UCLan`s patented research is developing a rapid detection kit to detect the presence of bacterial infections and distinguish them from viral infections.
UCLan`s patented technology enables the removal of pollutants through the use of a relatively inexpensive water-purifying composite material and processing technology that is environmentally benign.
UCLan patented research has developed and patented a quick release rescue harness that allows rescuers to enter the water safely, complete the rescue and be recovered to shore.
UCLan has developed and patented a series of new molecules that we hope one day could be advanced into a much needed new treatment for malignant brain tumours.
UCLan patented research is helping to develop low cost, personalized medicines which could soon be readily available thanks to 3D printer technology.
UCLan has developed and patented new and innovative sustainable composite materials made from household and industrial waste, which itself is recyclable.
UCLan patented research is utilising aptamers, ligand-binding fragments of aptamers, and oligonucleotides for use as agents in the prevention and/or treatments of cancers, and diagnosis of cancers.
UCLan research is developing solutions for the medical equipment market and in particular a dilator product for use in a clinical and home setting.
UCLan research is developing Rapidly Mutating (RM) YSTRs can differentiate between closely related males. A 13 locus multiplex PCR kit RM-YPlex was developed to simultaneously amplify them, in a robust and sensitive manner down to 0.0625ng template DNA.
UCLan patented research is developing new high performance fingerprint powders. These new powders have been developed from the surface modification of silica nano particles.
UCLan patented research using intelligent signal processing is being used to non-invasively track the increase of fluid in a bladder.
UCLan research has developed novel nanopowders which exhibit colour-tuneability in response to the wavelength of the incident radiation.
UCLan Researchers are developing a patented system for the integration of complex systems in areas such as aircraft, which usually involves assembling sub-systems in the same physical location and connecting them together for testing.